Helsinki - Free Realtime Quote EUR

Remedy Entertainment Oyj (REMEDY.HE)

16.58 +0.06 (+0.36%)
As of 11:40 AM GMT+3. Market Open.
Loading Chart for REMEDY.HE
DELL
  • Previous Close 16.52
  • Open 16.52
  • Bid 16.58 x --
  • Ask 16.66 x --
  • Day's Range 16.42 - 16.58
  • 52 Week Range 15.66 - 30.65
  • Volume 882
  • Avg. Volume 13,737
  • Market Cap (intraday) 224.704M
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) --
  • EPS (TTM) -1.68
  • Earnings Date Apr 29, 2024
  • Forward Dividend & Yield 0.10 (0.59%)
  • Ex-Dividend Date Apr 14, 2023
  • 1y Target Est 21.70

Remedy Entertainment Oyj, a video game company, engages in the development and sale of games for PC and console platforms in Finland. It primarily creates story-driven and visually stunning action games. The company also provides franchises under the Alan Wake, Control, and Max Payne brand names. Remedy Entertainment Oyj was incorporated in 1995 and is headquartered in Espoo, Finland.

www.remedygames.com

352

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: REMEDY.HE

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

REMEDY.HE
34.72%
MSCI WORLD
4.80%

1-Year Return

REMEDY.HE
31.20%
MSCI WORLD
17.49%

3-Year Return

REMEDY.HE
64.36%
MSCI WORLD
12.73%

5-Year Return

REMEDY.HE
110.65%
MSCI WORLD
53.14%

Compare To: REMEDY.HE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: REMEDY.HE

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    223.89M

  • Enterprise Value

    200.13M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.66

  • Price/Book (mrq)

    3.30

  • Enterprise Value/Revenue

    5.90

  • Enterprise Value/EBITDA

    -8.72

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -66.77%

  • Return on Assets (ttm)

    -14.99%

  • Return on Equity (ttm)

    -29.03%

  • Revenue (ttm)

    33.93M

  • Net Income Avi to Common (ttm)

    -22.66M

  • Diluted EPS (ttm)

    -1.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    27.42M

  • Total Debt/Equity (mrq)

    5.40%

  • Levered Free Cash Flow (ttm)

    -8.16M

Research Analysis: REMEDY.HE

Analyst Price Targets

19.00
21.70 Average
16.58 Current
27.00 High
 

Fair Value

 

Company Insights: REMEDY.HE

People Also Watch